Europe Market for Neurovascular Stents 2017 - MedCore is a new market research publication announced by Reportstack.
General Report Contents• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The total neurovascular stent market includes both traditional neurovascular stents and flow diversion stents. There will a slight decrease in market value of the neurovascular stent market due to price decreases from competitive pressure in the stent market and in other new medical devices for the treatment of aneurysms.
Traditional stents are experiencing a slight decline in units sold due to the cannibalization of the market by flow diverter stents. The use of the latter is becoming more popular than stent assisted coiling which is limiting the growth in the traditional stent market. Approximately 1.1 stents are used per stenting procedure, as a small percentage of patients require multiple stents.
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The total neurovascular stent market includes both traditional neurovascular stents and flow diversion stents. There will a slight decrease in market value of the neurovascular stent market due to price decreases from competitive pressure in the stent market and in other new medical devices for the treatment of aneurysms.
Traditional stents are experiencing a slight decline in units sold due to the cannibalization of the market by flow diverter stents. The use of the latter is becoming more popular than stent assisted coiling which is limiting the growth in the traditional stent market. Approximately 1.1 stents are used per stenting procedure, as a small percentage of patients require multiple stents.
Complete report available @ Europe Market for Neurovascular Stents 2017 - MedCore
Flow diverter stents will continue to experience low growth; however, they will also face competition from new products posed to enter the market. These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations.
The price of the flow diverter stents is significantly higher than the price of traditional stents and will remain high over the forecast period. Both types of stents will experience a reduction in their ASP due to competitive pressure. There are heavy price pressures seen with the stents, as smaller new entrants enter the market with significantly lower prices. The flow diverter stent will decrease at a slightly quicker rate since it is currently at such a high price premium and will need to stay competitive with innovative new products. Over the forecast period, the flow diverter stents will make up a larger portion of the market than the traditional stents. This trend will continue unless more evidence arises to demonstrate the safety and efficacy of traditional stents.
The price of the flow diverter stents is significantly higher than the price of traditional stents and will remain high over the forecast period. Both types of stents will experience a reduction in their ASP due to competitive pressure. There are heavy price pressures seen with the stents, as smaller new entrants enter the market with significantly lower prices. The flow diverter stent will decrease at a slightly quicker rate since it is currently at such a high price premium and will need to stay competitive with innovative new products. Over the forecast period, the flow diverter stents will make up a larger portion of the market than the traditional stents. This trend will continue unless more evidence arises to demonstrate the safety and efficacy of traditional stents.
Scope
2013-2023
2013-2023
Companies Mentioned
Medtronic Stryker Codman & Shurtleff, Inc. St. Jude Medical Nevro Carl Zeiss Boston Scientific LivaNova Terumo MicroVention Penumbra Inc. Leica Integra LifeSciences BrainLab Balt Magstim Phenox MagVenture Elekta Moëller Wedel Misonix Sophysa Aesculap MAG & More Neurosoft Acandis Soring Brainsway Nexstim Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
No comments:
Post a Comment